ASP Isotopes (ASPI) to Release Earnings on Friday

Posted by Brenda Bartman on Aug 12th, 2026

ASP Isotopes (NASDAQ:ASPI – Get Free Report) will likely be announcing its Q2 2026 results before the market opens on Friday, August 14th. Analysts expect ASP Isotopes to post earnings of ($0.17) per share and revenue of $4.4660 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Friday, August 21, 2026 at 4:00 PM ET.

ASP Isotopes (NASDAQ:ASPI – Get Free Report) last issued its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.06. The firm had revenue of $8.36 million during the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

ASP Isotopes Price Performance

ASPI opened at $4.32 on Wednesday. The company has a market capitalization of $662.30 million, a price-to-earnings ratio of -2.08 and a beta of 3.61. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average price of $5.37 and a 200-day moving average price of $5.50. ASP Isotopes has a twelve month low of $3.51 and a twelve month high of $14.49.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a report on Tuesday, April 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $13.00.

Check Out Our Latest Research Report on ASP Isotopes

Insider Buying and Selling at ASP Isotopes

In other ASP Isotopes news, CEO Paul Elliot Mann sold 83,759 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $7.76, for a total value of $649,969.84. Following the transaction, the chief executive officer directly owned 9,579,845 shares in the company, valued at $74,339,597.20. This represents a 0.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Michael Gorley sold 30,000 shares of the firm’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $6.27, for a total value of $188,100.00. Following the completion of the sale, the director directly owned 87,908 shares in the company, valued at approximately $551,183.16. The trade was a 25.44% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 279,079 shares of company stock valued at $2,049,208 over the last 90 days. Insiders own 14.40% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Mercer Global Advisors Inc. ADV boosted its holdings in shares of ASP Isotopes by 8.3% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock worth $203,000 after purchasing an additional 1,622 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of ASP Isotopes by 9.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock valued at $153,000 after purchasing an additional 1,878 shares during the last quarter. Legal & General Group Plc raised its holdings in shares of ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after buying an additional 1,953 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after buying an additional 2,548 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in ASP Isotopes by 9.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock worth $148,000 after buying an additional 2,709 shares during the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.